S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q3 2025

Deep Track Capital

Period: Q3 2025 Β· Filed: 2025-11-14
View on SEC EDGAR β†—
AUM
$3.58B
Total portfolio value
Positions
56
Reported securities
Top Holding
GH
7.2% $259.6M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
GHGUARDANT HEALTH INC$259.6M7.24%$62.48$167.98+168.8%
7.2%
IONSIONIS PHARMACEUTICALS INC$249.1M6.95%$65.42$81.80+25.0%
7.0%
CYTKCYTOKINETICS INC$236.3M6.60%$54.96$86.49+57.4%
6.6%
AKROAKERO THERAPEUTICS INC$190.0M5.30%β€”β€”
5.3%
APLSAPELLIS PHARMACEUTICALS INC$181.1M5.05%$22.63β€”
5.0%
TARSTARSUS PHARMACEUTICALS INC$178.3M4.98%$59.43$65.44+10.1%
5.0%
IMVTIMMUNOVANT INC$156.8M4.38%$16.12$38.79+140.6%
4.4%
DVAXDYNAVAX TECHNOLOGIES CORP$156.2M4.36%β€”β€”
4.4%
OCULOCULAR THERAPEUTIX INC$139.5M3.89%$11.69$9.64-17.5%
3.9%
ETNB89BIO INC$137.5M3.84%β€”β€”
3.8%
GPCRSTRUCTURE THERAPEUTICS INC$118.0M3.29%$28.00$53.45+90.9%
3.3%
VRDNVIRIDIAN THERAPEUTICS INC$116.1M3.24%$21.58$19.40-10.1%
3.2%
PTGXPROTAGONIST THERAPEUTICS INC$114.0M3.18%$66.43$131.62+98.1%
3.2%
AXSMAXSOME THERAPEUTICS INC$109.3M3.05%$121.45$244.31+101.2%
3.0%
PCVXVAXCYTE INC$108.1M3.02%$36.02$58.39+62.1%
3.0%
MAZEMAZE THERAPEUTICS INC$102.4M2.86%$25.93$31.26+20.6%
2.9%
IMCRIMMUNOCORE HLDGS PLC$65.4M1.82%$36.33$32.50-10.5%
1.8%
BBIOBRIDGEBIO PHARMA INC$62.3M1.74%$51.94$77.19+48.6%
1.7%
GERNGERON CORP$56.3M1.57%$1.37$1.36-0.7%
1.6%
TERNTERNS PHARMACEUTICALS INC$56.3M1.57%$7.51β€”
1.6%
NRIXNURIX THERAPEUTICS INC$56.0M1.56%$9.24$23.97+159.4%
1.6%
MBXMBX BIOSCIENCES INC$55.1M1.54%$17.50$57.80+230.3%
1.5%
EXASEXACT SCIENCES CORP$54.7M1.53%β€”β€”
1.5%
LBRXLB PHARMACEUTICALS INC$52.9M1.48%$15.79$33.43+111.7%
1.5%
CLDXCELLDEX THERAPEUTICS INC NEW$51.7M1.44%$25.87$38.37+48.3%
1.4%
ORKAORUKA THERAPEUTICS INC$51.0M1.42%$19.23$85.21+343.1%
1.4%
XENEXENON PHARMACEUTICALS INC$48.2M1.34%$40.15$60.96+51.8%
1.3%
CMPSCOMPASS PATHWAYS PLC$45.0M1.26%$5.73$13.62+137.7%
1.3%
ANIPANI PHARMACEUTICALS INC$41.2M1.15%$91.60$86.03-6.1%
1.1%
BCAXBICARA THERAPEUTICS INC$38.3M1.07%$15.79$29.00+83.7%
1.1%

Quarter-on-Quarter Activity

Q3 2025 vs. Q2 2025

New Positions (8)

TickerIssuerNotionalSince Filing
EXASEXACT SCIENCES CORP$54.7M
LBRXLB PHARMACEUTICALS INC$52.9M+111.7%
QUREUNIQURE NV$28.2M
DYNDYNE THERAPEUTICS INC$25.3M
GMABGENMAB A/S$14.8M
TNGXTANGO THERAPEUTICS INC$12.2M
IMAIMAGENEBIO INC$7.2M
CRMDCORMEDIX INC$5.8M

Exited Positions (8)

TickerIssuerNotional
INSMINSMED INC$176.1M
RAREULTRAGENYX PHARMACEUTICAL IN$49.1M
DNTHDIANTHUS THERAPEUTICS INC$41.6M
MTSRMETSERA INC$31.1M
TECXTECTONIC THERAPEUTIC INC$27.9M
ABVXABIVAX SA$26.6M
UPBUPSTREAM BIO INC$15.8M
MRUSMERUS N V$14.5M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
TARSTARSUS PHARMACEUTICALS INC$107.4M+71.4%+10.1%
MBXMBX BIOSCIENCES INC$30.1M+43.9%+230.3%
PCVXVAXCYTE INC$38.2M+39.5%+62.1%
ORKAORUKA THERAPEUTICS INC$29.5M+38.4%+343.1%
BBIOBRIDGEBIO PHARMA INC$23.5M+33.3%+48.6%
AKROAKERO THERAPEUTICS INC$27.6M+31.5%
CDTXCIDARA THERAPEUTICS INC$16.6M+20.0%
CYTKCYTOKINETICS INC$115.7M+17.8%+57.4%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
ZURAZURA BIO LTD$-0.7M-85.0%
AUTLAUTOLUS THERAPEUTICS PLC$-34.2M-84.8%
AVTXAVALO THERAPEUTICS INC$-1.0M-74.5%
CLYMCLIMB BIO INC$-0.3M-51.0%
ENGNENGENE HOLDINGS INC$-1.3M-50.9%
PTGXPROTAGONIST THERAPEUTICS INC$-65.4M-47.1%+98.1%
MNMDMIND MEDICINE MINDMED INC$1.5M-40.0%
GHRSGH RESEARCH PLC$-6.5M-37.5%
← Back to Hedge Funds